Dr. Lal PathLabs Ltd
Dr. Lal PathLabs Ltd (LALPATHLAB) last traded at ₹1,906, a market capitalisation of ₹31,992 crore, on a P/E of 56.9. Over the past 52 weeks the stock has ranged between ₹1,272 and ₹1,989. Dr. Lal PathLabs Ltd last reported results for the quarter ended Jun 2026, with sales of ₹798 crore and net profit of ₹170 crore. Figures are as of 25 Aug 2026 and are not real time.
Dr. Lal PathLabs Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Dr. Lal PathLabs Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹798 cr, up 19.1% from ₹670 cr a year earlier. Net profit was ₹170 cr, up 26.9% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 660 | 597 | 603 | 670 | 731 | 660 | 703 | 798 |
| Expenses | 458 | 443 | 434 | 478 | 506 | 480 | 516 | 550 |
| Operating profit | 202 | 154 | 169 | 192 | 224 | 179 | 187 | 248 |
| OPM % | 31% | 26% | 28% | 29% | 31% | 27% | 27% | 31% |
| Other income | 22 | 25 | 26 | 28 | 25 | -6 | 24 | 32 |
| Interest | 6 | 5 | 5 | 5 | 5 | 7 | 6 | 6 |
| Depreciation | 35 | 36 | 36 | 35 | 40 | 42 | 45 | 44 |
| Profit before tax | 183 | 138 | 153 | 181 | 204 | 124 | 160 | 229 |
| Tax % | 29% | 29% | -1% | 26% | 25% | 26% | 17% | 25% |
| Net profit | 131 | 98 | 156 | 134 | 152 | 91 | 132 | 170 |
| EPS (₹) | 7.73 | 5.78 | 9.26 | 7.90 | 8.99 | 5.40 | 7.84 | 10.11 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Dr. Lal PathLabs Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 1,581 | 2,087 | 2,017 | 2,227 | 2,461 | 2,763 | 2,891 |
| Operating profit | 436 | 561 | 490 | 609 | 698 | 783 | 838 |
| OPM % | 28% | 27% | 24% | 27% | 28% | 28% | 29% |
| Net profit | 296 | 350 | 241 | 362 | 492 | 510 | 546 |
| EPS (₹) | 17.49 | 20.69 | 14.33 | 21.42 | 29.14 | 30.13 | 32.34 |
TTM is the trailing twelve months to the most recent quarter.
Dr. Lal PathLabs Ltd growth and returns
- 10 Years
- 13%
- 5 Years
- 12%
- 3 Years
- 11%
- TTM
- 14%
- 10 Years
- 15%
- 5 Years
- 12%
- 3 Years
- 30%
- TTM
- 10%
- 10 Years
- 15%
- 5 Years
- 0%
- 3 Years
- 20%
- 1 Year
- 12%
- 10 Years
- 22%
- 5 Years
- 21%
- 3 Years
- 22%
- Last Year
- 22%
Dr. Lal PathLabs Ltd shareholding pattern
Promoters held 53.19% at Jun 2026, down from 53.79% at Jun 2025. FIIs 17.35% and DIIs 21.59%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 53.92% | 53.91% | 53.91% | 53.79% | 53.21% | 53.21% | 53.21% | 53.19% |
| FIIs | 26.82% | 26.82% | 23.90% | 21.69% | 21.86% | 20.29% | 17.18% | 17.35% |
| DIIs | 12.60% | 12.88% | 15.79% | 17.62% | 18.22% | 19.20% | 21.37% | 21.59% |
| Government | 0.29% | 0.29% | 0.29% | 0.29% | 0.27% | 0.01% | 0.01% | 0.01% |
| Public | 6.02% | 5.82% | 5.84% | 6.22% | 6.07% | 6.94% | 7.88% | 7.48% |
| No. of shareholders | 1,16,606 | 1,16,236 | 1,15,699 | 1,18,656 | 1,12,703 | 1,16,167 | 1,14,527 | 1,11,037 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Dr. Lal PathLabs Ltd corporate filings
- AttachedCompany Updatelow impact
Cruxal's analysis: Dr. Lal PathLabs Ltd has announced the incorporation of a new step-down subsidiary…
Read the full analysis - AttachedCompany Updatelow impact
Cruxal's analysis: Dr. Lal PathLabs has completed the allotment of equity shares pursuant to the exercise of…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Dr. Lal PathLabs Ltd
Cruxal reads every Dr. Lal PathLabs Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.